Public signalCompany raiseAuto-indexed · Unverified
Aspire BioPharma, Inc. raised $227K
Aspire BioPharma, Inc.· HUMACAO, US· Filed Feb 7, 2024
Aspire BioPharma, Inc. reported raising capital. Based in HUMACAO, PR, US. Automatically indexed from a public SEC EDGAR Form C filing. Details beyond the filing have not been verified.
Raised
$226,792
Confidence85%
Raised
$226,792
Incorporated
2021-09-27
Jurisdiction
PR
On the record
- Location
- HUMACAO, US
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $226,792
- Target amount
- $5.0M
- Filing date
- Feb 7, 2024
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- Sector is not classified in the source filing
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction
- PR
- Date incorporated
- 2021-09-27
- Entity type
- Corporation
- Employees
- 0.00
- Offering amount
- $150,000
- Maximum offering
- $5.0M
- Revenue (recent FY)
- $0
- Total assets (recent FY)
- $4.9M
- Security offered
- Preferred Stock
- Funding portal
- OpenDeal Portal LLC
- Offering deadline
- 2024-01-31
Sources & provenance
“Reg CF progress update reports 226,792 USD raised; offering closed.”
View original filing (SEC EDGAR Form C)
Automatically indexed from SEC EDGAR Form C · filing dated Feb 7, 2024. Details beyond the filing have not been verified.
Tags
USCompany$100K – $1MCompany Raise
Are you associated with Aspire BioPharma, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record